Alkermes plc (NASDAQ:ALKS).
July 29 investment analysts at Jefferies held the company rating at “Overweight” but lowered the price expectation from $78.00 to $66.00. On July 29 Barclays kept the company rating at “Overweight” and raised the price target to $66.00 from $65.00.
On July 26 the company was upgraded from “Market Perform” to “Market Perform” in a statement from Cowen & Company. July 13 investment analysts at Barclays maintained a company rating of “Overweight” but moved down the price target to $65.00 from $83.00.
On May 26 analysts at Evercore ISI Group starting coverage on ALKS by announcing an initial rating of “Buy”.
The company is up from yesterday’s close of $48.58. Shares last traded at $49.20 which is slightly above $46.78, the 50 day moving average and a tad above the 200 day moving average of $42.98. The 50 day moving average moved up $2.42 and the 200 day average moved up $6.22.
As of the last earnings report the EPS was $-1.83 and is estimated to be $-0.12 for the current year with 151,556,000 shares outstanding. Next quarter’s EPS is expected be $0.05 with next year’s EPS anticipated to be $0.38.
Traders are more bearish on shares of Alkermes plc recently if you put credence in the increase in short interest. The firm saw a rise in short interest of 0.06% as of September 15, 2016 from the last reporting period. Short interest increased from 4,873,349 to 5,186,406 over that timeframe. The short-interest ratio decreased to 6.3 and the percentage of shorted shares is 0.03% as of September 15.